Admissions:
None
Delistings:
None
What’s baking in the oven?
Potential** Initial Public Offerings:***
12th August: B HODL, has announced its application for admission to the AQSE growth market. The company is focused on generating low-risk, sustainable revenue through operational activities focused on the acquisition, accumulation and management of Bitcoin. The company’s initial business model centres around the operation of Lightning Network nodes, which generate revenue by charging fees for routing Bitcoin transactions. By leveraging the scalability and efficiency of the Lightning Network, B HODL aims to capitalise on transaction fee income and provide inbound liquidity to other Lightning node operators as its first lines of business. Deal details TBC and expected admission to be on or around 29 August 2025.
11th August: HRC World, has announced its application for admission to the AQSE growth market. The company is a data centre facilities operator specialising in the provision of small to medium-scale data centre facilities, server co-location, rack rentals, and a comprehensive range of technology infrastructure services. HRC stands for High Resiliency Co-Location services, emphasising its focus on delivering robust, secure, and highly reliable rack rental and hosting solutions. Currently, HRC World operates data centre facilities in Kuala Lumpur, Malaysia, strategically positioned to serve both regional and international markets, with plans for continued expansion across the Asia-Pacific region and beyond. Deal details TBC and expected admission is 26th August 2025. The company already trades on NASDAQ Copenhagen.
8th August: MedPal AI, the UK-based digital health and artificial intelligence Company focused on wellness management has released its Schedule One for an intended AIM IPO. The core product is a non-clinical, digital health app that aggregates and monitors users' health metrics and provides wellness guidance.
The Company intends to raise £1.6m at 4p with an anticipated market capitalisation on Admission of approximately £16m, for late August 2025.
24th July: Scotch Corner Designer Village, a newly formed single asset real estate company (to be re-registered as a public limited company) which is developing a retail outlet and leisure destination, announces it may consider an IPO on the newly launched Aquis Real Asset Market (ARAM) of the Aquis Stock Exchange. Timing and deal details TBC.
Banquet Buffet****
Aurrigo International 52.5p £30.42m (AURR.L)
The international provider of transport technology solutions has signed a new contract with Tees Valley Authority to deploy autonomous solutions at Teesside International Airport. The multi-year project will begin in H2 2025 and is worth £0.9m and will develop an autonomous baggage and passenger moving system at the airport. Following completion of the testing phase, the Auto-Shuttleand Auto-DollyTugwill be transferred to the Airport for airside testing and live operations. The project will culminate in 2026 in an Auto-Shuttleand Auto-DollyTugworking in conjunction airside to deliver people and bulk baggage autonomously around the airport. It is the first time Auto-Shuttle and Auto-DollyTug will be deployed together as an integrated solution in a live airport environment.
Cykel AI 1.675p £8.22m (CYK.L)
The creator of autonomous digital workers that perform complex business tasks announces a new product launch. GTM AI, is a zero-setup sales automation solution which is powered by the Company's autonomous AI sales agent Eve. This development will transform enterprise-grade sales automation from a technical challenge into an accessible business solution, enabling any organisation to deploy sophisticated go-to-market strategies without manual configuration. GTM AI automatically understands businesses and creates sophisticated outreach campaigns immediately upon deployment. GTM AI is intended to execute complete B2B sales workflows including autonomous prospecting, automated personalised outreach campaigns, intelligent lead qualification and nurturing through AI-generated follow-up sequences.
New Frontier Minerals 0.625p £10.3m (NFM.L)
The Australian-based explorer with a strategy to develop multi-commodity assets with potential to become an economic mining operation reports new targets. Its geology team has identified additional high-priority targets for drill-testing at its Harts Range Project, located 140km north-east of Alice Springs in the Northern Territory, Australia. Ahead of the upcoming drilling campaign, a 25kg bulk sample has been collected from the Cusp Prospect for comprehensive geochemical analysis. This marks an important milestone in executing a systematic exploration approach to ensure confidence in the project's potential.
Light Science Technologies 3.9p £12.64m (LST.L)
The innovative technology and manufacturing business providing real-world solutions targeting global food security and fire safety, announces interims to May 2025. Revenue eased to £5.1m from £5.2m
alongside a reduced Loss Before Tax by 51.2% to £0.16m. Cash was £1.1m compared to £1.0m with additional undrawn funds of around £0.7m against £0.5m available under debt facilities. The Passive Fire protection division contribution grew from 5.7% of revenue to 18.8% and is focused on near term cash generation. The company has increased the group’s quoted sales pipeline, currently worth over £58m, from £51m at the same time in 2024.
Oxford Biodynamics 0.375p £7.34m (OBD.L)
The biotechnology company pioneering the use of 3D genomic biomarkers for clinical diagnostics, announces a collaboration with Google Cloud to support the development and deployment of OBD's analytical framework on the cloud. It’s an important milestone in the digital transformation and utilisation of its knowledge base. The Google Cloud will enable OBD to scale its proprietary EpiSwitch knowledge space and analytical tools and deliver high-throughput, AI-powered 3D genomic analytics in a secure, efficient, and globally accessible environment. The Group is excited to be developing a powerful and interoperable platform, with Google that aligns with the future of cloud-native biomedical research.
Shoe Zone 68.5p £31.7m (SHOE.L)
The Town Centre, Retail Park and Digital footwear retailer updates on Trading for the months of June and July 2025. The Company has experienced challenging trading conditions as there has been less discretionary spending and decreased footfall, with a resultant reduction in revenue and profit. The Company expects the adjusted profit before tax for the FY September 2025 to be approximately £2.5m, down from previous expectations of £5.0m and dividend is being withdrawn. The company remains debt free and cash levels are currently higher than the same period last year. Management remains confident with the underlying strategy and the 200th new formatted store is opening shortly.
Sunda Energy 0.026p £7.45m (SNDA.L)
The explorer and appraisal company focused on gas assets in Southeast Asia, updates on its existing business and new venture activities. A revised proposal from the Timor-Leste helicopter company has been received for support of the planned offshore drilling operations at Chuditch and is being reviewed. The Company is also engaged with several rig operators in preparation for a full tender exercise to enable the delated drilling campaign to restart. Sunda is actively engaged in the pursuit of several new business initiatives to expand and diversify its upstream portfolio. The target opportunities are potentially material and would be highly impactful if secured. Despite the setback of the drilling the team looks forward to significant progress in the coming months.
Ultimate Products 54p £45.28m (ULTP.L)
The owner of a number of leading homeware brands including Salter (the UK's oldest houseware brand, est.1760) and Beldray (est.1872), reports on trading for FY July 2025. Revenues of £150.1m, are 3.4% lower reflecting subdued consumer demand for general merchandise. Third-party clearance & own label sales, which grew strongly during FY24 as suppliers dealt with their overstocks, declined by 48% to £13.8m. However, sales of the UP brands rose by 4.3% to £121.9m. The adjusted EBITDA was £12.5m, down 31%, impacted by additional freight costs as operating costs remained stable at £22.3m. The group had net bank debt of £14.1m is up from £10.4m. Trading is in line with subdued expectations. A change of listing from the Main Market to AIM is under consideration.
Winking Studios 14.25p £62.75m (WKS.L)
The global AAA game art outsourcing studios and established game development company reports interims to June 2025. Revenue increased 27.3% to £19.2m with adjusted net profit up 21.1% to £1.4m, although unadjusted net profit was unchanged at £0.9m. Resilient game outsourcing services demand, was reported with follow-up projects contributing 38.8% of revenue against 44.1% in H1 2024. Healthy balance sheet with cash and cash equivalents and bond investments of US$27.1m and zero debt as at 30 June 2025 (31 December 2024: US$41.3m and zero debt). This supports the M&A strategy, expansion in Western markets and to establish a UK office as a strategic foothold. The Board believes the Asian gaming market is experiencing a strong recovery, led by mobile gaming, which continues to drive the demand for art outsourcing.
XP Factory 10.25p £18.65m (XPF.L)
The leisure business operating the Escape Hunt and Boom Battle Bar brands, is to report full year to March 2025 on 1 September 2025. Recent trading has seen a marked turnaround in like-for-like sales performance in both brands following a challenging Q1. The strong costs controls and supplier negotiations has largely offset the negatives, and the Board remains cautiously optimistic about meeting the market expectations for the full year.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
